Microenvironment Regulation of Zika Virus Susceptibility in Human Brain Development and Malignant Glioma
- Funded by Wellcome Trust
- Total publications:2 publications
Grant number: 223011
Grant search
Key facts
Disease
Zika virus diseaseStart & end year
20222026Known Financial Commitments (USD)
$1,086,069.6Funder
Wellcome TrustPrincipal Investigator
Dr. Harry BulstrodeResearch Location
United KingdomLead Research Institution
Cambridge University Hospitals NHS Foundation TrustResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen morphology, shedding & natural history
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Neural stem cells (NSCs) in the developing embryo brain share transcription programs with glioma stem cells (GSCs) in malignant brain tumours, and both are susceptible to Zika Virus infection. In the developing brain this can result in microcephaly, whereas in brain tumours it could offer insights relevant to oncolytic virus development. However GSC and NSC susceptibility to Zika and other viruses depends on the microenvironment. In particular, microglia progenitors migrating into the embryo brain from the yolk sac are believed to bring virus with them, whereas my preliminary data suggests that mature tumour-associated microglia instead drive a virus resistance phenotype in GSCs. This project seeks to establish the mechanistic basis for the microenvironment regulation of virus susceptibility in normal and malignant progenitors, and to suggest therapeutic strategies for modulation of these.
Publicationslinked via Europe PMC
Last Updated:an hour ago
View all publications at Europe PMC